Cemdisiran Linked With Fewer Hospitalizations in Myasthenia Gravis Study

(MedPage Today) -- Cemdisiran, an investigational small interfering RNA (siRNA) therapeutic targeting complement component 5 (C5), led to fewer hospitalized myasthenia gravis patients compared with placebo, a prespecified exploratory analysis of...